Genpact Sees 9% EPS Growth, Trades at 9.34 P/E After 21.6% Drop
Genpact expects EPS to grow 9% this year versus an 8.7% industry average, with sales forecast at 6.5% and a 0.95 sales-to-assets ratio. The stock trades at 9.34 forward P/E, PEG 0.99, has fallen 21.6% in four weeks and is considered oversold as analysts lift earnings estimates 2.9%.
1. Growth Outlook
Genpact projects 9% EPS growth in 2026 versus an industry average of 8.7%, with sales expected to rise 6.5%. The company’s sales-to-assets ratio stands at 0.95, indicating efficient use of assets to generate revenue.
2. Valuation Profile
Shares trade at a forward P/E of 9.34, a PEG ratio of 0.99 and a P/B ratio of 2.51, metrics that support a top-tier Value grade compared with sector peers. These valuation levels suggest the stock is trading at a discount relative to its growth prospects.
3. Technical Position & Estimate Revisions
The stock has declined 21.6% over the past four weeks, pushing it into oversold territory on technical indicators. During the same period, analysts raised full-year earnings estimates by 2.9%, reflecting improving sentiment on profit outlook.